Celsion (CLSN) to Release Quarterly Earnings on Tuesday

Celsion (NASDAQ:CLSN) is set to issue its quarterly earnings data before the market opens on Tuesday, March 27th. Analysts expect the company to announce earnings of ($0.31) per share for the quarter.

Shares of Celsion (NASDAQ CLSN) opened at $2.47 on Monday. Celsion has a 52-week low of $1.24 and a 52-week high of $6.06. The company has a market capitalization of $43.80, a PE ratio of -0.42 and a beta of 1.80.

How to Become a New Pot Stock Millionaire

A number of analysts have commented on CLSN shares. ValuEngine raised Celsion from a “strong sell” rating to a “sell” rating in a research report on Wednesday, March 7th. Zacks Investment Research raised Celsion from a “sell” rating to a “hold” rating in a research report on Tuesday, December 19th. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average target price of $11.90.

WARNING: “Celsion (CLSN) to Release Quarterly Earnings on Tuesday” was posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this news story on another site, it was illegally stolen and reposted in violation of United States and international trademark and copyright law. The legal version of this news story can be viewed at https://www.tickerreport.com/banking-finance/3300762/celsion-clsn-to-release-quarterly-earnings-on-tuesday.html.

About Celsion

Celsion Corporation, an oncology drug company, focuses on the development and commercialization of directed chemotherapy, DNA-mediated immunotherapy, and RNA based therapy products for the treatment of cancer. The company's lead product includes ThermoDox, a liposomal encapsulation of doxorubicin that is in Phase III clinical trials for primary liver cancer; and under Phase II clinical trials for recurrent chest wall breast cancer.

Earnings History for Celsion (NASDAQ:CLSN)

Receive News & Ratings for Celsion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celsion and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

UBS Group  Given a CHF 18 Price Target by Cfra Analysts
UBS Group Given a CHF 18 Price Target by Cfra Analysts
Canaccord Genuity Increases Detour Gold  Price Target to C$24.00
Canaccord Genuity Increases Detour Gold Price Target to C$24.00
ABB  PT Set at CHF 28 by Kepler Capital Markets
ABB PT Set at CHF 28 by Kepler Capital Markets
Klondex Mines  PT Raised to C$3.00 at Canaccord Genuity
Klondex Mines PT Raised to C$3.00 at Canaccord Genuity
CIBC Increases Transcontinental  Price Target to C$34.00
CIBC Increases Transcontinental Price Target to C$34.00
Deutsche Bank  Shares Gap Up to $14.25
Deutsche Bank Shares Gap Up to $14.25


© 2006-2018 Ticker Report. Google+.